Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations
Background:. Most botulinum toxin A (BoNT/A) products contain unnecessary bacterial components that increase the risk of developing neutralizing antibodies (nAbs). Reports of secondary nonresponse and treatment failures (STF) due to nAbs have accompanied a surge in new BoNT/A products. Methods:. To...
Main Authors: | Je-Young Park, MD, Niamh Corduff, MBBS, Jürgen Frevert, PhD, Rungsima Wanitphakdeedecha, MD, MA, MSc, Yates Y.Y. Chao, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-04-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004217 |
Similar Items
-
Sensory Symptoms Associated with Aesthetic Botulinum Toxin A Treatments
by: Niamh Corduff, MBBS, FRACS
Published: (2022-11-01) -
Surgical or Nonsurgical Facial Rejuvenation: The Patients’ Choice
by: Niamh Corduff, MBBS
Published: (2023-10-01) -
Botulinumtoxin Improves both Generic and Disease-Specific Quality of Life in Cervical Dystonia
by: Daniel Weiss, et al.
Published: (2017-10-01) -
Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients
by: Priya Jagota, et al.
Published: (2016-08-01) -
Addressing the Real-World Challenges of Immunoresistance to Botulinum Neurotoxin A in Aesthetic Practice: Insights and Recommendations from a Panel Discussion in Hong Kong
by: Wilson W. S. Ho, et al.
Published: (2023-07-01)